DGAP-Adhoc: MOLOGEN AG fixes subscription price for capital increase from Authorized Capital at EUR 2.10

Publication of an insider information pursuant to Section 17 of the regulation (EU) No. 596/2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

MOLOGEN AG fixes subscription price for capital increase from Authorized Capital at EUR 2.10

Berlin, 18 March 2019 - The Executive Board of MOLOGEN AG (ISIN DE000A2LQ900, SIN A2L Q90) (the "Company") today fixed, with the approval of the Company's Supervisory Board, the subscription price for the capital increase against contributions in cash with indirect subscription rights for existing shareholders resolved on 13 March 2019 at EUR 2.10.

The subscription rights will be publicly offered to the Company's existing shareholders in accordance with the terms of the subscription offer (Bezugsangebot) and without a prospectus pursuant to section 3 para. 2 sentence 1 no. 5 and section 4 para. 2 sentence 1 of the German Securities Prospectus Act (Wertpapierprospektgesetz) in conjunction with art. 1 para. 5 subpara. 1 lit. a) of Regulation (EU) 2017/1129.

The subscription offer with further information and further risk notes is expected to be published on or about 18 March 2019 on the Company's website at https://www.mologen.com/de/investors/share/capital-measures and in the Federal Gazette.

Important note:

This announcement is not an offer of securities for sale in the United States, Australia, Canada, Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in this press release have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offering of the securities in the United States of America. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan.